Mebeverine Zydus

Mebeverine Hydrochloride, the active ingredient in Mebeverine Zydus, is an antispasmodic (smooth muscle relaxant) presented as an oral tablet for oral use. It is employed to alleviate abdominal discomfort and altered bowel habits associated with irritable bowel syndrome and other functional bowel disorders.

GNH USA supplies Mebeverine Zydus as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global distribution.

Mebeverine Hydrochloride acts on gastrointestinal smooth muscle to relieve spasm and related symptoms. It is indicated for: - Irritable bowel syndrome: reduces abdominal pain, cramping and irregular bowel movements. - Functional bowel disorders: improves overall bowel habit and decreases discomfort. - Spastic colon: alleviates colonic smooth‑muscle spasms and associated pain.

Mebeverine Hydrochloride is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Dry mouth: reduced salivation causing throat discomfort. - Headache: transient cranial pain. - Dizziness: occasional light‑headed sensation. - Abdominal cramps: mild lingering discomfort. - Constipation: reduced bowel frequency.

Serious or Rare Side Effects: - Allergic reactions: rash, itching, or angioedema. - Severe hypotension: marked drop in blood pressure. - Cardiac arrhythmia: irregular heart rhythm. - Hepatic dysfunction: abnormal liver enzyme elevations. - Stevens‑Johnson syndrome: severe skin blistering.

Before prescribing Mebeverine Hydrochloride, consider the following precautions: - Pregnancy: safety not established; avoid unless clearly needed. - Breastfeeding: unknown safety; weigh benefits against potential risks. - Renal impairment: use with caution and monitor renal function. - Elderly patients: increased susceptibility to side effects; start at lowest effective dose. - Drug interactions: review concomitant medications for potential additive antispasmodic effects. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Mebeverine Hydrochloride may interact with other medicines. Review patient medication lists carefully.

Major Interactions (Avoid): - Other antispasmodics: risk of excessive smooth‑muscle relaxation. - Strong CYP3A4 inhibitors: may increase mebeverine plasma concentrations.

Moderate Interactions (Monitor Closely): - Antihistamines: possible additive sedation. - Beta‑blockers: monitor heart rate and blood pressure. - Diuretics: watch for electrolyte disturbances. - Anticholinergic agents: enhanced anticholinergic burden. - Oral contraceptives: potential alteration of hormone levels.